Solution conformations of the substrates and inhibitor of hepatitis C virus NS3 protease

被引:0
|
作者
Lee, JH
Bang, K
Jung, JW
Ahn, IA
Ro, S
Lee, W
机构
[1] Yonsei Univ, Coll Sci, Dept Biochem, Seoul 120740, South Korea
[2] LG Chem, Biotech Res Inst, Taejon 305380, South Korea
关键词
D O I
暂无
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Hepatitis C virus (HCV) has been known to be an enveloped virus with a positive strand RNA genome and the major agent of the vast majority of transfusion associated cases of hepatitis. For viral replication, HCV structural proteins are first processed by host cell signal peptidases and NS2/NS3 site of the nonstructural protein is cleaved by a zinc-dependent protease NS2 with N-terminal NS3. The four remaining junctions are cleaved by a separate NS3 protease. The solution conformations of NS4B/5A, NS5A/5B substrates and NS5A/5B inhibitor have been determined by two-dimensional nuclear magnetic resonance (NMR) spectroscopy. NMR data suggested that the both NS5A/5B substrate and inhibitor appeared to have a folded turn-like conformation not only between P1 and P6 position but also C-terminal region, whereas the NS4B/5A substrate exhibited mostly extended conformation. In addition, we have found that the conformation of the NS5A/5B inhibitor slightly differs from that of NS5A/5B substrate peptide, suggesting different binding mode for NS3 protease. These findings will be of importance for designing efficient inhibitor to suppress HCV processing.
引用
收藏
页码:301 / 306
页数:6
相关论文
共 50 条
  • [41] NS3 Serine Protease as a Target for Anti-Hepatitis C Virus
    Saleh, Noha A.
    Elshemey, Wael M.
    Elsayed, Anwar A.
    Ibrahim, Medhat
    REVIEWS IN THEORETICAL SCIENCE, 2015, 3 (03) : 257 - 263
  • [42] IN-VITRO CLEAVAGE OF HEPATITIS-C VIRUS POLYPROTEIN SUBSTRATES BY PURIFIED RECOMBINANT NS3 PROTEASE
    DSOUZA, EDA
    GRACE, K
    SANGAR, DV
    ROWLANDS, DJ
    CLARKE, BE
    JOURNAL OF GENERAL VIROLOGY, 1995, 76 : 1729 - 1736
  • [43] Chimeric sindbis viruses dependent on the NS3 protease of hepatitis C virus
    Filocamo, G
    Pacini, L
    Migliaccio, G
    JOURNAL OF VIROLOGY, 1997, 71 (02) : 1417 - 1427
  • [44] Detection and analysis of hepatitis C virus NS3 serine protease inhibitors
    Zemel, R
    Bachmatove, L
    Berdichevsky, Y
    Kunin, M
    Golan-Goldhirsh, A
    Benhar, I
    Tur-Kaspa, R
    JOURNAL OF HEPATOLOGY, 2001, 34 : 126 - 127
  • [45] The quest for hepatitis C virus NS3 serine protease inhibitors.
    Tur-Kaspa, R
    Berdichevsky, Y
    Zemel, R
    Bachmatov, L
    Lamed, R
    HEPATOLOGY, 2000, 32 (04) : 562A - 562A
  • [46] Novel, sulfonamide linked inhibitors of the hepatitis C virus NS3 protease
    Kirschberg, Thorsten A.
    Squires, Neil H.
    Yang, Huiling
    Corsa, Amoreena C.
    Tian, Yang
    Tirunagari, Neeraj
    Sheng, X. Christopher
    Kim, Choung U.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2014, 24 (03) : 969 - 972
  • [47] Molecular docking of peptide inhibitors to the hepatitis C virus NS3 protease
    Shenderovich, M
    Wang, J
    Fisher, C
    Ramnarayan, K
    Abagyan, R
    PEPTIDES FOR THE NEW MILLENNIUM, 2000, : 472 - 473
  • [48] Computational Modelling in Studies for Hepatitis C Virus (HCV) NS3 Protease
    Mukhametov, Azat
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2016, 16 (12) : 1351 - 1361
  • [49] Hepatitis C virus NS3 serine protease as a drug discovery target
    McPhee, F
    Yeung, KS
    Good, AC
    Meanwell, NA
    DRUGS OF THE FUTURE, 2003, 28 (05) : 465 - 488